SK-MEL-28

A hypotetraploid melanoma cell line established from a 51 year old male patient with cutaneous melanoma.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1979-2018
0102019792018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Dihydromyricetin (DHM) exhibits multiple pharmacological activities; however, the role of DHM in anti-melanoma activities and the… (More)
  • table I
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2011
2011
Mitogen-activated protein kinase kinases (MKK or MEK) 1 and 2 are usually treated as redundant kinases. However, in assessing… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2009
2009
Plants are an important source of several clinically useful anti-cancer agents. A volatile extract was obtained from Ricinus… (More)
Is this relevant?
2008
2008
Human melanoma cell lines, SK-MEL-3 and SK-MEL-28, despite induction of the proapoptotic cytokine, Apo2L/TRAIL, did not undergo… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
The metabolism and toxicity of ethyl 4-hydroxybenzoate (4-HEB) were investigated in vitro using tyrosinase enzyme, a melanoma… (More)
Is this relevant?
2007
2007
The expression of melanotransferrin (MTf), a membrane-bound glycoprotein highly expressed in melanomas, is correlated with tumor… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2005
2005
Sigma receptors are present in cancer cell lines. The aim of the present study is to evaluate the anti-tumor activity of a series… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
GD3, a ganglioside expressed on human melanoma, can be recognized by the humoral immune system. In this paper, we demonstrate… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2001
2001
N(1),N(11)-Diethylnorspermine (DENSPM) is a polyamine analogue with clinicalrelevance as an experimental anticancer agent and the… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2001
2001
The chimeric monoclonal antibody KM871, directed against the G(D3) antigen, is under evaluation for its potential to target… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
Is this relevant?